CMG has announced a split. Makes sense to make shares more affordable but fractionals are
widely available. CMG may be fundamentally challenged by the underpinnings of the fast food
markets. that is overeating and rising prices. In the meanwhile the anti-obesity and anti-
diabetes trends are pushing hard led by the bological injectable meds from LLY, NVO and
others. One third of the people eat one half of the food and now an effective treatment
for that addiction is becoming increasingly available. The writing is on the wall and food biz
executives can read that writing. Enough said.
I am going short on CMG. It's best days of growth may behind it. The company announced plans
for 4000 more stores nationwide. Really? Time will tell. I vote with my wallet. My position
will not be small. The predictive algo has its forecast. My education included both medicine
and engineering. I understand the power of biology and mathematics. I deeply respect
both.
widely available. CMG may be fundamentally challenged by the underpinnings of the fast food
markets. that is overeating and rising prices. In the meanwhile the anti-obesity and anti-
diabetes trends are pushing hard led by the bological injectable meds from LLY, NVO and
others. One third of the people eat one half of the food and now an effective treatment
for that addiction is becoming increasingly available. The writing is on the wall and food biz
executives can read that writing. Enough said.
I am going short on CMG. It's best days of growth may behind it. The company announced plans
for 4000 more stores nationwide. Really? Time will tell. I vote with my wallet. My position
will not be small. The predictive algo has its forecast. My education included both medicine
and engineering. I understand the power of biology and mathematics. I deeply respect
both.
Transaction en cours
Resistance 2985-3015 Price moved down a little to finish out the week/month and quarter ( fade from smart money longs realizing profits and new shorts taking newpositions- myself included). On to April
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.